Stay updated on Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The study Locations section now lists Connecticut, Florida, Indiana, New Jersey, New York, Pennsylvania, and Vermont as sites. A new revision note v3.3.3 appears on the page, and the HHS Vulnerability Disclosure footer link has been removed.
    Difference
    0.8%
    Check dated 2025-12-24T14:40:07.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The update shows a minor revision from v3.3.1 to v3.3.2. No substantive study content or user-facing features appear to be affected.
    Difference
    0.0%
    Check dated 2025-12-01T17:31:08.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    A new page revision label was added (v3.3.1) replacing the previous v3.2.0. There is no evident change to the study details, eligibility criteria, or outcomes in the visible content.
    Difference
    0.0%
    Check dated 2025-11-24T14:39:37.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The government funding lapse notice was removed from the page. It previously warned that information may not be up to date and that inquiries could be delayed.
    Difference
    0.3%
    Check dated 2025-11-17T06:52:39.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    No significant changes detected in the Study Details page for NCT03743662; the study’s core content and structure appear unchanged compared to the previous view. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:20:41.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Major changes: version updated to v3.2.0 and a prominent notice about government funding and operating status. Removed reference to v3.1.0.
    Difference
    4%
    Check dated 2025-10-05T10:25:13.000Z thumbnail image

Stay in the know with updates to Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial page.